Latest News

Page 2 of 2512345...1020...Last »

December 21, 2016

Fovista® Fails Final Test For Wet AMD Treatment

Posted in: Latest News, Research and Developments

Fovista®, a once-promising experimental drug for treatment of wet macular degeneration, has failed to show positive results in Phase 3 trials. This is surprising, since, on June 14, 2012, Ophthotech Corporation reported a 62% higher relative visual benefit when Fovista (1.5 mg) was used in combination with Lucentis in Phase 2b clinical trials. Based upon those
read more »

December 6, 2016

Photobiomodulation—A New Treatment For Dry AMD?

Posted in: Latest News, Research and Developments

A new non-invasive technology from LumiThera Inc. may help improve vision in  people with dry age-related macular degeneration. Photobiomodulation involves exposure of the retina to light from diodes emitting red, yellow, and infrared wavelengths. Researchers in Switzerland and Toronto recently found that treating eyes three times a week for three weeks improved best corrected visual
read more »

December 6, 2016

More Responders Needed for AMD Survey

Posted in: Latest News

The Cochrane Eyes and Vision US Satellite (CEV@US), located at The Johns Hopkins Bloomberg School of Public Health (JHBSPH) is conducting an important survey to identify research priorities for age-related macular degeneration (AMD). Their previous request for participants in the survey has yielded 35 responses so far, but at least 50 are needed. The survey will take
read more »

November 22, 2016

Eye Drops for Wet AMD Showing Positive Results

Posted in: Latest News, Research and Developments

Eye drops continue to show promise as future treatments for wet AMD and other eye diseases involving blood vessel growth and hemorrhaging in the retina. In a presentation at the 2015 Ophthalmology Innovation Summit at the American Academy of Ophthalmology. Paul G. Chaney (President and CEO of Panoptica) reported preliminary results from the PAN-90806 clinical
read more »

November 16, 2016

NHTSA sets ‘Quiet Car’ safety standard

Posted in: Latest News

New requirement of audible alert will help prevent 2,400 pedestrian injuries a year The U.S. Department of Transportation’s National Highway Traffic Safety Administration (NHTSA) is adding a sound requirement for all newly manufactured hybrid and electric light-duty vehicles to help protect pedestrians. The new federal safety standard will help pedestrians who are blind, have low vision, and
read more »

October 13, 2016

FDA Grants Priority Review for Myopic CNV Treatment

Posted in: Latest News, Research and Developments

Genentech, makers of Lucentis® (ranibizumab injection) for wet AMD, has been approved for Priority Review by the FDA to study Lucentis for the treatment of myopic choroidal neovascularization (mCNV). Also known as degenerative myopia, mCNV is a complication of severe near-sightedness that can lead to uncorrectable visual impairment. The FDA’s approval is based on results from the Phase
read more »

September 12, 2016

Webinar on Making Eye Health a Population Health Imperative: Vision for Tomorrow

Posted in: Latest News

An important report on making eye health a population health imperative is scheduled to be released to the public on Thursday, September 15. Following its release, a webinar is scheduled for Tuesday, September 20, from 2:00 until 3:15 Central Time to share highlights of the report. This is part of a consensus study by the Health and
read more »

September 10, 2016

Combined Therapies May Help Restore Vision Loss From Glaucoma

Posted in: Latest News, Research and Developments

Past studies have shown that high-contrast visual stimulation can help damaged retinal neurons regrow optic nerve fibers. By combining that knowledge with new research showing that increased activity of a protein called mTOR promotes optic nerve regeneration, scientists are hoping for a way to restore sight lost to glaucoma and other optic neuropathies. So far,
read more »

August 10, 2016

Is Blindness The “Worst Ailment”?

Posted in: Daily Living, Latest News, Low Vision Rehabilitation, Research and Developments

by Dan Roberts A recent online nationwide poll (1) has joined similar past studies in revealing that people consider vision loss to be the “worst ailment that could happen to them relative to losing memory, speech, hearing, or a limb.” The researchers’ intent was to “underscore the importance of focusing on preservation of eye health and the
read more »

July 27, 2016

Finally, A Promising Breakthrough For Dry AMD

Posted in: Latest News, Research and Developments

Genentech, Inc., a leading pharmaceutical developer, is currently conducting two phase III trials studying the drug lampalizumab as a potential treatment for advanced dry macular degeneration, also known as geographic atrophy (GA). Patients who have been diagnosed with GA are encouraged to participate in the trials, which are being conducted at hundreds of locations in
read more »

Page 2 of 2512345...1020...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann